Oxygen-limiting conditions enrich for fimbriate cells of uropathogenic Proteus mirabilis and Escherichia coli

Journal of Bacteriology

Volumn 191, Issue 5, 2009, Pages 1382-1392

  Lane, M Chelsea ^a   Li, Xin ^b   Pearson, Melanie M ^a   Simms, Amy N ^a   Mobley, Harry L T ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN; REGULATOR PROTEIN; BACTERIAL PROTEIN; FIMBRIA PROTEIN; RECOMBINASE;

ARTICLE; BACTERIAL GROWTH; CELL DENSITY; CELL HYPOXIA; DISEASE COURSE; ESCHERICHIA COLI; FIMBRIA; OPERON; OXYGENATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEUS MIRABILIS; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; CBA MOUSE; CULTURE MEDIUM; DRUG EFFECT; ESCHERICHIA COLI INFECTION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; MICROBIOLOGY; MOUSE; PROTEUS INFECTION; URINARY TRACT INFECTION;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; PROTEUS MIRABILIS;

ANIMALS; BACTERIAL PROTEINS; CULTURE MEDIA; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FIMBRIAE PROTEINS; FIMBRIAE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MICE; MICE, INBRED CBA; OXYGEN; PROTEUS INFECTIONS; PROTEUS MIRABILIS; RECOMBINASES; SIGNAL TRANSDUCTION; URINARY TRACT INFECTIONS;

EID: 62649174901     PISSN: 00219193     EISSN: None     Source Type: Journal    
DOI: 10.1128/JB.01550-08     Document Type: Article

References (62)

1. Abraham, J. M., C. S. Freitag, J. R. Clements, and B. I. Eisenstein. 1985. An invertible element of DNA controls phase variation of type 1 fimbriae of Escherichia coli. Proc. Natl. Acad. Sci. USA 82:5724-5727.
2. Adegbola, R. A., and D. C. Old. 1983. Fimbrial haemagglutinins in Enterobacter species. J. Gen. Microbiol. 129:2175-2180.
3. Bahrani, F. K., D. E. Johnson, D. Robbins, and H. L. Mobley. 1991. Proteus mirabilis flagella and MR/P fimbriae: isolation, purification, N-terminal analysis, and serum antibody response following experimental urinary tract infection. Infect. Immun. 59:3574-3580.
4. Belas, R., D. Erskine, and D. Flaherty. 1991. Transposon mutagenesis in Proteus mirabilis. J. Bacteriol. 173:6289-6293.
5. Blomfield, I. C., P. J. Calie, K. J. Eberhardt, M. S. McClain, and B. I. Eisenstein. 1993. Lrp stimulates phase variation of type 1 fimbriation in Escherichia coli K-12. J. Bacteriol. 175:27-36.
6. Blomfield, I. C., M. S. McClain, J. A. Princ, P. J. Calie, and B. I. Eisenstein. 1991. Type 1 fimbriation and fimE mutants of Escherichia coli K-12. J. Bacteriol. 173:5298-5307.
7. Bryan, A., P. Roesch, L. Davis, R. Moritz, S. Pellett, and R. A. Welch. 2006. Regulation of type 1 fimbriae by unlinked FimB- and FimE-like recombinases in uropathogenic Escherichia coli strain CFT073. Infect. Immun. 74: 1072-1083.
8. Burall, L. S., J. M. Harro, X. Li, C. V. Lockatell, S. D. Himpsl, J. R. Hebel, D. E. Johnson, and H. L. Mobley. 2004. Proteus mirabilis genes that contribute to pathogenesis of urinaiy tract infection: identification of 25 signature-tagged mutants attenuated at least 100-fold. Infect. Immun. 72:2922-2938.
9. Cecchini, G., I. Schroder, R. P. Gunsalus, and E. Maklashina. 2002. Succinate dehydrogenase and fumarate reductase from Escherichia coli. Biochim. Biophys. Acta 1553:140-157.
10. Cohen-Ben-Lulu, G. N., N. R. Francis, E. Shimoni, D. Noy, Y. Davidov, K. Prasad, Y. Sagi, G. Cecchini, R. M. Johnstone, and M. Eisenbach. 2008. The bacterial flagellar switch complex is getting more complex. EMBO J. 27: 1134-1144.
11. Collet, J. F., and J. C. Bardwell. 2002. Oxidative protein folding in bacteria. Mol. Microbiol. 44:1-8.
12. De Wulf, P., O. Kwon, and E. C. C. Lin. 1999. The CpxRA signal transduction system of Escherichia coli: growth-related autoactivation and control of unanticipated target operons. J. Bacteriol. 181:6772-6778.
13. Dorman, C., J., and C. F. Higgins. 1987. Fimbrial phase variation in Escherichia coli: dependence on integration host factor and homologies with other site-specific recombinases. J. Bacteriol. 169:3840.
14. Dove, S. L., S. G. Smith, and C. J. Dorman. 1997. Control of Escherichia coli type 1 fimbrial gene expression in stationary phase: a negative role for RpoS. Mol. Gen. Genet. 254:13-20.
15. Eisenstein, B. I., D. S. Sweet, V. Vaughn, and D. I. Friedman. 1987. Integration host factor is required for the DNA inversion that controls phase variation in Escherichia coli. Proc. Natl. Acad. Sci. USA 84:6506-6510.
16. Finlay, B. B., and S. Falkow. 1997. Common themes in microbial pathogenicity revisited. Microbiol. Mol. Biol. Rev. 61:136-169.
17. Gaily, D. L., J. Leathart, and I. C. Blomfield. 1996. Interaction of FimB and FimE with the fim switch that controls the phase variation of type 1 fimbriae in Escherichia coli K-12. Mol. Microbiol. 21:725-738.
18. Gunther, N. W., V. Lockatell, D. E. Johnson, and H. L. Mobley. 2001. In vivo dynamics of type 1 fimbria regulation in uropathogenic Escherichia coli during experimental urinary tract infection. Infect. Immun. 69:2838.
19. Gunther, N. W. t., J. A. Snyder, V. Lockatell, I. Blomfield, D. E. Johnson, and H. L. Mobley. 2002. Assessment of virulence of uropathogenic Escherichia coli type 1 fimbrial mutants in which the invertible element is phase-locked on or off. Infect. Immun. 70:3344-3354.
20. Hagberg, L., I. Engberg, R. Freter, J. Lain, S. Oiling, and C. Svanborg Eden. 1983. Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin. Infect. Immun. 40:273-283.
21. Hannan, T. J., I. U. Mysorekar, S. L. Chen, J. N. Walker, J. M. Jones, J. S. Pinkner, S. J. Hultgren, and P. C. Seed. 2008. LeuX tRNA-dependent and -independent mechanisms of Escherichia coli pathogenesis in acute cystitis. Mol. Microbiol. 67:116-128.
22. Higgins, C. F., C. J. Dorman, D. A. Stirling, L. Waddell, I. R. Booth, G. May, and E. Bremer. 1988. A physiological role for DNA supercoiling in the osmotic regulation of gene expression in S. typhimurium and E. coli. Cell 52:569.
23. Himpsl, S. D., C. Y. Lockatell, J. R. Hebel, D. E. Johnson, and H. L. Mobley. 2008. Identification of virulence determinants in uropathogenic Proteus mirabilis using signature-tagged mutagenesis. J. Med. Microbiol. 57:1068-1078.
24. Humphries, A. D., M. Raffatellu, S. Winter, E. H. Weening, R. A. Kingsley, R Droleskey, S. Zhang, J. Figueiredo, S. Khare, J. Nunes, L. G. Adams, R M. Tsolis, and A. J. Baumler. 2003. The use of flow cytometry to detect expression of subunits encoded by 11 Salmonella enterica serotype Typhimurium fimbrial opérons. Mol. Microbiol. 48:1357-1376.
25. Hung, D. L., T. L. Raivio, C. H. Jones, T. J. Silhavy, and S. J. Hultgren. 2001. Cpx signaling pathway monitors biogenesis and affects assembly and expression of P pili. EMBO J. 20:1508-1518.
26. Jacob-Dubuisson, F., J. Pinkner, Z. Xu, R. Striker, A. Padmanhaban, and S. J. Hultgren. 1994. PapD chaperone function in pilus biogenesis depends on oxidant and chaperone-like activities of DsbA. Proc. Natl. Acad. Sci. USA 91:11552-11556.
27. Jacobsen, S. M., M. C. Lane, J. M. Harro, M. E. Shirtliff, and H. L. Mobley. 2008. The high-affinity phosphate transporter Pst is a virulence factor for Proteus mirabilis during complicated urinary tract infection. FEMS Immunol. Med. Microbiol. 52:180-193.
28. Jansen, A. M., V. Lockatell, D. E. Johnson, and H. L. Mobley. 2004. Mannose-resistant Proteus-like fimbriae are produced by most Proteus mirabilis strains infecting the urinary tract, dictate the in vivo localization of bacteria, and contribute to biofilm formation. Infect. Immun. 72:7294-7305.
29. Johnson, D. E., C. V. Lockatell, M. Hall-Craigs, H. L. Mobley, and J. W. Warren. 1987. Uropathogenicity in rats and mice of Providentia stuartii from long-term catheterized patients. J. Urol. 138:632-635.
30. Kawula, T. H., and P. E. Orndorff. 1991. Rapid site-specific DNA inversion in Escherichia coli mutants lacking the histonelike protein H-NS. J. Bacteriol. 173:4116-4123.
31. Klemm, P. 1986. Two regulatory fim genes. fimB and fimE, control the phase variation of type 1 fimbriae in Escherichia coli. EMBO J. 5:1389-1393.
32. Krogfelt, K. A., H. Bergmans, and P. Klemm. 1990. Direct evidence that the FimH protein is the man nose-specific adhesin of Escherichia coli type 1 fimbriae. Infect. Immun. 58:1995-1998.
33. Lane, M. C., V. Lockatell, G. Monterosso, D. Lamphier, J. Weinert, J. R. Hebel, D. E. Johnson, and H. L. Mobley. 2005. Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract. Infect. Immun. 73:7644-7656.
34. Lee, C. A., and S. Falkow. 1990. The ability of Salmonella to enter mammalian cells is affected by bacterial growth state. Proc. Natl. Acad. Sci. USA 87:4304-4308.
35. Li, X., D. E. Johnson, and H. L. Mobley. 1999. Requirement of MrpH for mannose-resistant Proteus-like fimbria-media ted hemagglutination by Proteus mirabilis. Infect. Immun. 67:2822-2833.
36. Li, X., C. V. Lockatell, D. E. Johnson, and H. L. Mobley. 2002. Identification of MrpI as the sole recombinase that regulates the phase variation of MR/P fimbria, a bladder colonization factor of uropathogenic Proteus mirabilis. Mol. Microbiol. 45:865-874.
37. Li, X., D. A. Rasko, C. V. Lockatell, D. E. Johnson, and H. L. Mobley. 2001. Repression of bacterial motility by a novel fimbrial gene product. EMBO J. 20:4854-4862.
38. Manning, P. A. 1997. The tcp gene cluster of Vibrio cholerae. Gene 192:63-70.
39. Martinez, J. J., M. A. Mulvey, J. D. Schilling, J. S. Pinkner, and S. J. Hultgren. 2000. Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. EMBO J. 19:2803-2812.
40. McClain, M. S., L C. Blomfield, and B. I. Eisenstein. 1991. Roles of fimB and fimE in site-specific DNA inversion associated with phase variation of type 1 fimbriae in Escherichia coli. J. Bacteriol. 173:5308-5314.
41. Miller, V. L., R. K. Taylor, and J. J. Mekalanos. 1987. Cholera toxin transcriptional activator toxR is a transmembrane DNA binding protein. Cell 48:271-279.
42. Mobley, H. L., D. M. Green, A. L. Trifillis, D. E. Johnson, G. R. Chippendale, C. V. Lockatell, B. D. Jones, and J. W. Warren. 1990. Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect. Immun. 58:1281-1289.
43. Mobley, H. L., and J. W. Warren. 1987. Urease-positive bacteriuria and obstruction of long-term urinary catheters. J. Clin. Microbiol. 25:2216-2217.
44. Newman, J. V., R. L. Burghoff, L. Pallesen, K. A. Krogfelt, C. S. Kristensen, D. C. Laux, and P. S. Cohen. 1994. Stimulation of Escherichia coli F-18Col-type-1 fimbriae synthesis by leuX. FEMS Microbiol. Lett. 122:281-287.
45. Old, D. C., R. Adegbola, and S. S. Scott. 1983. Multiple fimbrial haemagglutinins in Serratia species. Med. Microbiol. Immunol. 172:107-115.
46. Old, D. C., and R. A. Adegbola. 1982. Haemagglutinins and fimbriae of Morganella, Proteus and Providentia. J. Med. Microbiol. 15:551.
47. Old, D. C., and J. P. Duguid. 1970. Selective outgrowth of fimbriate bacteria in static Uquid medium. J. Bacteriol. 103:447-456.
48. Pearson, M. M., and H. L. Mobley. 2008. Repression of motility during fimbrial expression: identification of 14 mrpJ gene paralogies in Proteus mirabilis. Mol. Microbiol. 69:548-558.
49. Pearson, M. M., and H. L. Mobley. 2007. The type III secretion system of Proteus mirabilis HI4320 does not contribute to virulence in the mouse model of ascending urinary tract infection. J. Med. Microbiol. 56:1277-1283.
50. Pearson, M. M., M. Sebaihia, C. Churcher, M. A. Quail, A. S. Seshasayee, N. M. Luscombe, Z. Abdellah, C. Arrosmith, B. Atkin, T. Chillingworth, H. Hauser, K. Jagels, S. Moule, K. Mungall, H. Norbertczak, E. Rabbinowitsch, D. Walker, S. Whithead, N. R. Thomson, P. N. Rather, J. Parkhill, and H. L. Mobley. 2008. Complete genome sequence of uropathogenic Proteus mirabilis, a master of both adherence and motility. J. Bacteriol. 190:4027-4037.
51. Raivio, T. L., and T. J. Silhavy. 2001. Periplasmie stress and ECF sigma factors. Annu. Rev. Microbiol. 55:591-624.
52. Ritter, A., D. L. Gaily, P. B. Olsen, U. Dobrindt, A. Friedrich, P. Klemm, and J. Hacker. 1997. The Pai-associa ted leuX specific tRNA5(Leu) affects type 1 fimbriation in pathogenic Escherichia coli by control of FimB recombinase expression. Mol. Microbiol. 25:871-882.
53. Schembri, M. A., and P. Klemm. 2001. Coordinate gene regulation by fimbriae-induced signal transduction. EMBO J. 20:3074-3081.
54. Snyder, J. A., B. J. Haugen, E. L. Buckles, C. Y. Lockatell, D. E. Johnson, M. S. Donnenberg, R. A. Welch, and H. L. Mobley. 2004. Transcriptome of uropathogenic Escherichia coli during urinaiy tract infection. Infect. Immun. 72:6373.
55. Soto, G. E., and S. J. Hultgren. 1999. Bacterial adhesins: common themes and variations in architecture and assembly. J. Bacteriol. 181:1059-1071.
56. Spears, P. A., D. Schauer, and P. E. Orndorff. 1986. Metastable regulation of type 1 piliation in Escherichia coli and isolation and characterization of a phenotypically stable mutant. J. Bacteriol. 168:179-185.
57. Swanson, J., S. Bergstrom, K. Robbins, O. Barrera, D. Corwin, and J. M. Koomey. 1986. Gene conversion involving the pilin structural gene correlates with pilus+ in equilibrium with pilus - changes in Neisseria gonorrhoeae. Cell 47:267-276.
58. van der Woude, M., B. Braaten, and D. Low. 1996. Epigenetic phase variation of the pap operon in Escherichia coli. Trends Microbiol. 4:5-9.
59. Willems, R., A. Paul, H. van der Heide, A. R. ter Avest, and F. R Mooi. 1990. Fimbrial phase variation in Bordetella pertussis: a novel mechanism for transcriptional regulation. EMBO J. 9:2803.
60. Xie, Y., Y. Yao, V. Kolisnychenko, C. H. Teng, and K. S. Kim. 2006. HbiF regulates type 1 fimbriation independently of FimB and FimE. Infect. Immun. 74:4039-4047.
61. Zhang, H. Z., and M. S. Donnenberg. 1996. DsbA is required for stability of the type IV pilin of enteropathogenic Escherichia coli. Mol. Microbiol. 21:787-797.
62. Zhao, H., X. Li, D. E. Johnson, I. Blomfield, and H. L. Mobley. 1997. In vivo phase variation of MR/P fimbrial gene expression in Proteus mirabilis infecting the urinary tract. Mol. Microbiol. 23:1009-1019.